Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYR | P14679 | 4/20 | 0.66 |
| ▸ | POLB | P06746 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | G6PD | P11413 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.46 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.46 |
| ▸ | CA12 | O43570 | 2/20 | 0.44 |
| ▸ | CA1 | P00915 | 2/20 | 0.44 |
| ▸ | CA2 | P00918 | 2/20 | 0.44 |
| ▸ | CA4 | P22748 | 2/20 | 0.44 |
| ▸ | CA5A | P35218 | 2/20 | 0.44 |
| ▸ | CA7 | P43166 | 2/20 | 0.44 |
| ▸ | CA9 | Q16790 | 2/20 | 0.44 |
| ▸ | CA3 | P07451 | 1/20 | 0.44 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.44 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.44 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL940139 | 1.00 | TYR (0.66) | TYRPOLBKDM4EGAAMAPT | |
| SCHEMBL9013983 | 1.00 | TYR (0.66) | TYRPOLBKDM4EGAAMAPT | |
| SCHEMBL7690243 | 1.00 | TYR (0.66) | TYRPOLBKDM4EGAAMAPT | |
| SCHEMBL18920263 | 1.00 | TYR (0.66) | TYRPOLBKDM4EGAAMAPT | |
| SCHEMBL435260 | 1.00 | TYR (0.66) | TYRPOLBKDM4EGAAMAPT | |
| SCHEMBL9014038 | 0.87 | TYR (0.51) | TYRPOLBKDM4EGAAMAPT | |
| SCHEMBL291103 | 0.86 | TYR (0.49) | TYR | |
| SCHEMBL6582069 | 0.86 | TYR (0.49) | TYRPOLB | |
| SCHEMBL21045067 | 0.86 | SLC5A2 (0.49) | TYRCA12CA9 | |
| SCHEMBL869387 | 0.86 | TYR (0.49) | TYR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200383897-A1 | BIOACTIVE COMPOSITIONS COMPRISING FICUS SERUM FRACTON AND METHODS TO REDUCE THE APPEARANCE OF SKIN HYPERPIGMENTATION | ISP INVESTMENTS LLC (US) | 2020-12-10 | — | — | US | disclosed |
| EP-0745719-A2 | Use of carbohydrate compounds as auxiliary agents in the dyeing or printing of fibrous materials | HOECHST AKTIENGESELLSCHAFT (DE) | 1996-12-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200383897-A1 | BIOACTIVE COMPOSITIONS COMPRISING FICUS SERUM FRACTON AND METHODS TO REDUCE THE APPEARANCE OF SKIN HYPERPIGMENTATION | CUTA, FIBP, FGF23 | TYR 39/4885POLB 2565/4885KDM4E 4127/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.